Potent antimicrobial action of triclosan-lysozyme complex against skin pathogens mediated through drug-targeted delivery mechanism

European Journal of Pharmaceutical Sciences

Volumn 42, Issue 1-2, 2011, Pages 130-137

  Hoq, Md Imranul ^a,b   Ibrahim, Hisham R ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CHITTAGONG   (Bangladesh)

Author keywords

Acne; Antibiotics; Antimicrobial; Bacterial fatty acid synthesis; Drug delivery; Drug targeting; Erythrasma; FabI; Lysozyme; Triclosan

Indexed keywords

CELL ENZYME; DRUG CARRIER; ENOYL ACP REDUCTASE; LYSOZYME; MULTIENZYME COMPLEX; OXIDOREDUCTASE; SODIUM CHLORIDE; TRICLOSAN; TRICLOSAN LYSOZYME COMPLEX; UNCLASSIFIED DRUG; WATER;

ACNE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; CANDIDA ALBICANS; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM MINUTISSIMUM; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SPECIFICITY; FATTY ACID SYNTHESIS; MALASSEZIA FURFUR; NONHUMAN; PH; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; SKIN FLORA; SKIN INFECTION; SOLUBILITY; STATISTICAL SIGNIFICANCE; YEAST;

ANTI-INFECTIVE AGENTS, LOCAL; CANDIDA ALBICANS; CORYNEBACTERIUM; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); HUMANS; HYDROGEN-ION CONCENTRATION; MALASSEZIA; MURAMIDASE; PROPIONIBACTERIUM ACNES; SKIN; SOLUBILITY; TRICLOSAN;

EID: 78650678043     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.11.002     Document Type: Article

References (36)

1. H. Arima, H.R. Ibrahim, T. Kinoshita, and A. Kato Bactericidal action of lysozymes attached with various sizes of hydrophobic peptides to the C-terminus using genetic modification FEBS Lett. 415 1997 114 118
2. H. Arima, T. Kinoshita, H.R. Ibrahim, H. Azakami, and A. Kato Enhanced secretion of hydrophobic peptide fused lysozyme by the introduction of N-glycosylation signal and the disruption of calnexin gene in Saccharomyces cerevisiae FEBS Lett. 440 1998 89 92
3. A.K. Arsan, S. Sizmaz, S.B. Ozkan, and S. Duman Corynebacterium minutissimum endophthalmitis: management with antibiotic irrigation of the capsular bag Int. Ophthalmol. 19 1996 313 316
4. A. Bandera, A. Gori, and M.C. Rossi A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient J. Infect. 41 2000 103 105
5. H.N. Bhargava, and P.A. Leonard Triclosan: applications and safety Am. J. Infect. Control 24 1996 209 218
6. J. Cavendish, J.B. Cole, and C.A. Ohl Polymicrobial central venous catheter sepsis involving a multiantibiotic-resistant strain of Corynebacterium minutissimum Clin. Infect. Dis. 19 1994 204 205
7. K. Chikakane, and H. Takahashi Measurement of skin pH and its significance in cutaneous diseases Clin. Dermatol. 13 1995 299 306
8. J. Craig, W. Grigor, B. Doyle, and D. Arnold Pyelonephritis caused by Corynebacterium minutissimum Pediatr. Infect. Dis. J. 13 1994 1151 1152
9. T. Ganz Antimicrobial polypeptides J. Leukoc. Biol. 75 2004 34 38
10. T. Ganz, V. Gabayan, H.I. Liao, L. Liu, A. Oren, and T. Graf Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan Blood 101 2003 2388 2392
11. J. Guarderas, A. Karnad, S. Alvarez, and S.L. Berk Corynebacterium minutissimum bacteremia in a patient with chronic myeloid leukemia in blast crisis Diagn. Microbiol. Infect. Dis. 5 1986 327 330
12. J.C. Gunsolley A meta-analysis of six-month studies of antiplaque and antigingivitis agents J. Am. Dent. Assoc. 137 2006 1649 1657
13. R.J. Heath, S.W. White, and C.O. Rock Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics Appl. Microbiol. Biotechnol. 58 2002 695 703
14. B.J. Herschorn, and A.J. Brucker Embolic retinopathy due to Corynebacterium minutissimum endocarditis Br. J. Ophthalmol. 69 1985 29 31
15. M.I. Hoq, T. Aoki, and H.R. Ibrahim Triclosan-lysozyme complex: a promising anti-microbial macromolecule stable against photooxidative damage Food Res. Int. 42 2009 298 306
16. M.I. Hoq, K. Mitsuno, Y. Tsujino, T. Aoki, and H.R. Ibrahim Triclosan-lysozyme complex as novel antimicrobial macromolecule: a new potential of lysozyme as phenolic drug-targeting molecule Int. J. Biol. Macromol. 42 2008 468 477
17. H.R. Ibrahim, A. Kato, and K. Kobayashi Antimicrobial effects of lysozyme against Gram-negative bacteria due to covalent binding of palmitic acid J. Agric. Food Chem. 39 1991 2077 2082
18. H.R. Ibrahim, K. Kobayashi, and A. Kato Length of hydrocarbon chain and antimicrobial action to Gram-negative bacteria of fatty acetylated lysozyme J. Agric. Food Chem. 41 1993 1164 1168
19. H.R. Ibrahim, U. Thomas, and A. Pellegrini A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action J. Biol. Chem. 276 2001 43767 43774
20. H.R. Ibrahim, M. Yamada, K. Kobayashi, and A. Kato Bactericidal action of lysozyme against Gram-negative bacteria due to insertion of a hydrophobic pentapeptide into its C-terminus Biosci. Biotechnol. Biochem. 56 1992 1361 1363
21. H.R. Ibrahim, M. Yamada, K. Matsushita, K. Kobayashi, and A. Kato Enhanced bactericidal action of lysozyme to Escherichia coli by inserting a hydrophobic pentapeptide into its C-terminus J. Biol. Chem. 269 1994 5059 5063
22. E. Ingham The immunology of Propionibacterium acnes and acne Curr. Opin. Infect. Dis. 12 1999 191 197
23. I. Ishige, Y. Usui, T. Takemura, and Y. Eishi Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis Lancet 354 1999 120 123
24. M.W. Konstan, P.W. Cheng, and T.F. Boat A comparative study of lysozyme and its secretion by tracheal epithelium Exp. Lung Res. 3 1982 175 181
25. M. Lores, M. LIompart, L. Sanchez-Prado, C. Garcia-Jares, and R. Cela Confirmation of the formation of dichlorodibenzo-p-dioxin in the photodegradation of triclosan by photo-SPME Anal. Bioanal. Chem. 381 2005 1294 1298
26. G. Marquis, S. Montplaisir, S. Garzon, H. Strykowski, and P. Auger Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans Lab. Invest. 46 1982 627 636
27. F.S. Panagakos, A.R. Volpe, M.E. Petrone, W. DeVizio, R.M. Davies, and H.M. Proskin Advanced oral antibacterial/anti-inflammatory technology: a comprehensive review of the clinical benefits of a triclosan/copolymer/fluoride dentifrice J. Clin. Dent. 16 2005 S1 S19
28. E.M. Prager, and P. Jolles Animal lysozymes c and g: an overview EXS. 75 1996 9 31
29. M.E. Rupp, K.G. Stiles, S. Tarantolo, and R.V. Goering Central venous catheter-related Corynebacterium minutissimum bacteremia Infect. Control Hosp. Epidemiol. 19 1998 786 789
30. J. Santos-Juanes, C. Galache, A. Martinez-Cordero, J.R. Curto, M.P. Carrasco, and A. Ribas Cutaneous granulomas caused by Corynebacterium minutissimum in an HIV-infected man J. Eur. Acad. Dermatol. Venereol. 16 2002 643 645
31. H.P. Schweizer Triclosan: a widely used biocide and its link to antibiotics FEMS Microbiol. Lett. 202 2001 1 7
32. E.P. Segundo, A. Ganem-Quintanar, V. Alonso-Perez, and D. Quintanar-Guerrero Preparation and characterization of triclosan nanoparticles for periodontal treatment Int. J. Pharm. 294 2005 217 232
33. J.K. Swanson Antibiotic resistance of Propionibacterium acnes in acne vulgaris Dermatol. Nurs. 15 2003 359 362
34. M. Toyoda, and M. Morohashi Pathogenesis of acne Med. Electron Microsc. 34 2001 29 40
35. B. Van Bosterhaut, R. Cuvelier, E. Serruys, F. Pouthier, and G. Wauters Three cases of opportunistic infection caused by propionic acid producing Corynebacterium minutissimum Eur. J. Clin. Microbiol. Infect. Dis. 11 1992 628 631
36. S.P. Yazdankhah, A.A. Scheie, E.A. Hoiby, B.T. Lunestad, E. Heir, T.O. Fotland, K. Naterstad, and H. Kruse Triclosan and antimicrobial resistance in bacteria: an overview Microb. Drug Resist. 12 2006 83 90